New drug may cut transfusion needs for rare bone marrow disorder
NCT ID NCT05181592
First seen Nov 01, 2025 · Last updated May 01, 2026 · Updated 31 times
Summary
This study tests a drug called luspatercept in 70 adults with a low-risk form of myelodysplastic syndromes (MDS) that includes ring sideroblasts. The goal is to see if the drug can reduce or eliminate the need for red blood cell transfusions. Participants receive the drug as an injection, and researchers track transfusion independence over several weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYELODYSPLASTIC SYNDROMES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Clinica di Ematologia Istituto oncologico della Svizzera Italiana
Bellinzona, 6500, Switzerland
-
Hospital General Universitario Gregorio Marañón
Madrid, 28009, Spain
-
Hospital Universitario Central de Asturias
Oviedo, 33011, Spain
-
Hospital Universitario y Politecnico La Fe de Valencia
Valencia, 46026, Spain
-
Hospital Vall d´Hebron
Barcelona, 08023, Spain
-
Institut Català d' Oncologia de Badalona
Badalona, 8916, Spain
-
Klinikum rechts der Isar
München, 81675, Germany
-
Medizinische Universität Innsbruck
Innsbruck, 6020, Austria
-
Medizinische Universität Wien
Vienna, 1090, Austria
-
University Hospital of Salamanca
Salamanca, 37007, Spain
-
Universitätsklinik für Hämatologie und Hämatologisches Zentrallabor
Bern, 3010, Switzerland
-
Universitätsklinikum Leipzig
Leipzig, 04103, Germany
-
Universitätsspital Basel
Basel, 4031, Switzerland
Conditions
Explore the condition pages connected to this study.